Cargando…

A patient with pleuroparenchymal fibroelastosis carrying a novel fibrillin-2 gene variant

Pleuroparenchymal fibroelastosis is a recently recognized clinical entity characterized by interstitial pneumonia with proliferating elastin in the upper lung regions. Pleuroparenchymal fibroelastosis is categorized as idiopathic or reported depending on the coexistent initiating factors; however, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Kouko, Inai, Tetsuichiro, Kosho, Tomoki, Yamaguchi, Tomomi, Kawabata, Yoshinori, Inai, Yuko, Imamura, Shogo, Sanada, Sakiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209443/
https://www.ncbi.nlm.nih.gov/pubmed/37251355
http://dx.doi.org/10.1016/j.rmcr.2023.101870
Descripción
Sumario:Pleuroparenchymal fibroelastosis is a recently recognized clinical entity characterized by interstitial pneumonia with proliferating elastin in the upper lung regions. Pleuroparenchymal fibroelastosis is categorized as idiopathic or reported depending on the coexistent initiating factors; however, congenital contractural arachnodactyly, which is caused by abnormal production of elastin based on a mutation in the fibrillin-2 gene, is rarely reported with lung lesion resembling pleuroparenchymal fibroelastosis. We present a case of pleuroparenchymal fibroelastosis in a patient with a novel mutation in the fibrillin-2 gene, which encodes the prenatal fibrillin-2 protein as a scaffold for elastin.